Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Testing appropriate patients with advanced non-small cell lung cancer (NSCLC) for ALK rearrangements and EGFR mutations is critically important to ensure delivery of the most effective lung cancer treatment.

Join Philip Kantoff, MD, and Paul Nguyen, MD, as they present their multidisciplinary expertise on a range of cases pertaining to prostate cancer.

Join Sam Chang, MD, and Lan Gellert, MD, PhD, as they present their multidisciplinary expertise on a range of cases pertaining to Kidney Cancer.

Join Anas Younes, MD, and Andrew Zelenetz, MD, PhD, as they present their multidisciplinary expertise on a range of cases pertaining to follicular lymphoma.

Join John Byrd, MD, and Gerard Lozanski, MD, as they present their multidisciplinary expertise on a range of cases pertaining to CLL/SLL.

This live webinar series is an educational program that addresses health care professionals' need to be educated on current and emerging evidence-based scientific data for accurate and timely clinical evaluation of patients with medullary thyroid cancer (MTC).

Join Renato Martins, MD, MPH and Douglas Wood, MD as they present their multidisciplinary expertise on a range of cases pertaining to squamous cell lung cancer.

This live 75-minute webcast, with interactive Q&A and patient-physician video case studies, is designed to meet the educational needs of physicians, nurses, pharmacists, and other health care professionals who manage patients with cancer.